| Website | dvssciences.com |
| Category | Consumer Electronics/Devices |
| Phone | 905-513-1704 |
| Employees |
| TOTAL | $14.6M |
| VENTURE FUNDING TOTAL | $14.6M |
| Series A, 7/11 5AM Ventures Mohr Davidow Ventures Pfizer Venture Investments | $14.6M |
DVS Sciences, Inc. manufactures and has global distribution of novel bioanalytical solutions for use in biomarker discovery, biological research and possible clinical applications. The patented multi-parameter solution comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF®, and a suite of MAXPAR® reagents, which include stable-isotope-tagged antibodies. The CyTOF – MAXPAR system overcomes the limitations of conventional flow cytometry, simplifies sample preparation and simultaneously identifies up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada and Asia.
